| Predicted Trait | |
| Reported Trait | Melanoma |
| Mapped Trait(s) | melanoma (EFO_0000756) |
| Additional Trait Information | Genes involved in the telomere, senescense, and other pathways |
| Score Construction | |
| PGS Name | PRS_melanoma_telomere.pathway |
| Development Method | |
| Name | Genome-wide significant variants |
| Parameters | SNPs with previously confirmed melanoma risk in genes involved in the telomere, senescence, and other pathways |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 9 |
| Effect Weight Type | log(OR) |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000151 |
| Citation (link to publication) | Cust AE et al. J Invest Dermatol (2018) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 36,077 individuals (100%) |
| PGS Evaluation | European: 100% 2 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST003061 Europe PMC: 26237428 |
36,077 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM001832 | PSS000927| European Ancestry| 1,035 individuals |
PGP000151 | Cust AE et al. J Invest Dermatol (2018) |
Reported Trait: Melanoma | OR: 1.15 [1.01, 1.31] | — | Odds Ratio (OR, top vs. bottom tertile): 1.4 [1.01, 1.93] | Age, sex, recruitment city, self-reported European ancestry | — |
| PPM001833 | PSS000928| European Ancestry| 1,460 individuals |
PGP000151 | Cust AE et al. J Invest Dermatol (2018) |
Reported Trait: Melanoma | OR: 1.18 [1.06, 1.31] | — | Odds Ratio (OR, top vs. bottom tertile): 1.55 [1.19, 2.02] Odds Ratio (OR, top vs. bottom decile): 2.0 [1.24, 3.23] |
Age, sex, self reported European ancestry | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000927 | Cases include invasive cutaneous melanoma diagnoses between ages 18 and 39 years | — | [ ,
40.0 % Male samples |
— | European | — | AMFS | — |
| PSS000928 | Cases include histopathologically confirmed invasive melanoma cases in patients between 18 and 82 years. | — | [ ,
40.0 % Male samples |
— | European | — | LMC | — |